Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2017 Jun 24. pii: S1569-1993(17)30770-1. doi: 10.1016/j.jcf.2017.06.002
Document
Link
Keywords
Ivacaftor [4]
Date
Saturday, June 24, 2017
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [7]